Showing results (1-10 of 95) with videos related to
Sort By:
Pageof 10
Interventional Cardiology Clinics|November 26, 2016
Protease-Activated Receptor-1 Antagonists Post-Percutaneous Coronary InterventionPierluigi TricociClinical Chemistry|January 8, 2017
Consensus or Controversy?: Evolution of Criteria for Myocardial Infarction After Percutaneous Coronary InterventionPierluigi TricociCurrent Opinion in Cardiology|October 3, 2008
Time to coronary angiography in patients with non-ST-segment elevation acute coronary syndrome: how fast should patients go to the catheterization laboratory?Pierluigi TricociCardiology in Review|February 19, 2008
GP IIb-IIIa inhibitors administered upstream: evidence for improved outcomes with conventional and newer antithrombotic agents?Pierluigi Tricoci, L Kristin NewbyJournal of Interventional Cardiology|October 6, 2006
The evolving role of glycoprotein IIb/IIIa inhibitor therapy in contemporary care of acute coronary syndrome patientsPierluigi Tricoci, Eric D PetersonExpert Opinion on Pharmacotherapy|July 31, 2015
Ticagrelor, prasugrel, or clopidogrel in ST-segment elevation myocardial infarction: which one to choose?Patrícia O Guimarães, Pierluigi TricociVascular Health and Risk Management|March 18, 2010
Safety and efficacy of abciximab as an adjunct to percutaneous coronary interventionJennifer Vergara-Jimenez, Pierluigi TricociJournal of Cardiovascular Translational Research|February 26, 2013
Novel anti-platelet agents: focus on thrombin receptor antagonistsFlavio de Souza Brito, Pierluigi TricociAdvances in Cardiology|August 22, 2012
Protease-activated receptor-1 inhibitors: a novel class of antiplatelet agents for the treatment of patients with acute coronary syndromeSergio Leonardi, Pierluigi Tricoci, Richard C BeckerCurrent Cardiology Reports|December 14, 2011
Promises of PAR-1 inhibition in acute coronary syndromeSergio Leonardi, Pierluigi Tricoci, Kenneth W MahaffeyPageof 10